These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36557826)

  • 41. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
    Qiu Y; Zhou L; Hu Y; Bao Y
    J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations.
    Huang Q; Lai T; Wang Q; Luo L
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Research progress of urotensin Ⅱ and urotensin Ⅱ receptor].
    Zhou R; Li L; Liu X; Du GH
    Yao Xue Xue Bao; 2016 May; 51(5):684-9. PubMed ID: 29874004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
    Kang KM; Lee I; Nam H; Kim YC
    Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
    Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
    J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histamine H
    Ghamari N; Zarei O; Reiner D; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
    Chem Biol Drug Des; 2019 May; 93(5):832-843. PubMed ID: 30586225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
    Carotenuto A; Auriemma L; Merlino F; Yousif AM; Marasco D; Limatola A; Campiglia P; Gomez-Monterrey I; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
    J Med Chem; 2014 Jul; 57(14):5965-74. PubMed ID: 24992374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α.
    Perricone U; Wieder M; Seidel T; Langer T; Padova A; Almerico AM; Tutone M
    ChemMedChem; 2017 Aug; 12(16):1399-1407. PubMed ID: 28135036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A combination of receptor-based pharmacophore modeling & QM techniques for identification of human chymase inhibitors.
    Arooj M; Sakkiah S; Kim S; Arulalapperumal V; Lee KW
    PLoS One; 2013; 8(4):e63030. PubMed ID: 23658661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of new agonists of urotensin-II from a cyclic peptide library.
    Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
    Bioorg Med Chem; 2009 Sep; 17(18):6742-7. PubMed ID: 19695883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid
    Nath V; Ahuja R; Kumar V
    J Biomol Struct Dyn; 2019 Sep; 37(14):3764-3787. PubMed ID: 30252605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.
    Lescot E; Bureau R; Rault S
    Peptides; 2008 May; 29(5):680-90. PubMed ID: 18022732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of selective farnesoid X receptor agonists for the treatment of hyperlipidemia from traditional Chinese medicine based on virtual screening and in vitro validation.
    Chen X; Lu F; Luo G; Ren Y; Ma J; Zhang Y
    J Biomol Struct Dyn; 2020 Sep; 38(15):4461-4470. PubMed ID: 31842697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacophore-based virtual screening, molecular docking and molecular dynamics simulations study for the identification of LIM kinase-1 inhibitors.
    Singh R; Pokle AV; Ghosh P; Ganeshpurkar A; Swetha R; Singh SK; Kumar A
    J Biomol Struct Dyn; 2023; 41(13):6089-6103. PubMed ID: 35862656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
    Mohebbi A
    J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of novel β3-adrenoceptor agonists using energetic analysis, structure based pharmacophores and virtual screening.
    Tewatia P; Malik BK; Sahi S
    Comb Chem High Throughput Screen; 2012 Sep; 15(8):623-40. PubMed ID: 22375887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
    Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
    J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.